Skip to content
Catalyst

PapersPMID:34836346

A Comparative Study of the Hepatoprotective Effect of Centella asiatica Extract (CA-HE50) on Lipopolysaccharide/d-galactosamine-Induced Acute Liver Injury in C57BL/6 Mice.

Nutrients2021The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, insufficient evidencelowersAspartate aminotransferase
  2. Finding, insufficient evidencelowersAlanine aminotransferase
Study, every finding
animal · not in humans · 14 days
  • “The AST levels decreased significantly in the CA-HE50, silymarin, LEM, UDCA and DDB administration groups compared to the vehicle control group (p < 0.01; Figure 3A).”
    Interests
    Industry funded
    Dose studied
    100 and 200 mg/kg CA-HE50 by oral gavage every 24 h for 2 weeks
    Population
    Male C57BL/6 mice with acute liver injury induced by intraperitoneal LPS and D-galactosamine after 2 weeks of pretreatment, compared with vehicle-treated injured mice
  • “In particular, ALT levels significantly decreased in the group administered 200 mg/kg of CA-HE50 (p < 0.01) and 200 mg/kg of DDB (p < 0.01; Figure 3B).”
    Interests
    Industry funded
    Dose studied
    200 mg/kg CA-HE50 by oral gavage every 24 h for 2 weeks
    Population
    Male C57BL/6 mice with acute liver injury induced by intraperitoneal LPS and D-galactosamine after 2 weeks of pretreatment, 200 mg/kg dose stratum only, compared with vehicle-treated injured mice

Study record

Design
animal study, in vivo
Species
animal
Population
Six-week-old C57BL/6 mice with lipopolysaccharide/D-galactosamine-induced acute liver injury, given oral Centella asiatica 50% ethanol extract (CA-HE50) or positive-control hepatoprotectants
Participants
48
Comparator
an active treatment / placebo
Duration
14 days
Endpoints measured
35